AKT1 and hepatocellular carcinoma: Zhang et al. (Zhang W et al., 2022) showed that miR-148a-3p was downregulated in HSCs and HSCs-derived exosomes, and exosomes-depleted miR-148a-3p accelerated HCC progression through ITGA5/PI3K/Akt axis.